EGFR and non-small cell lung carcinoma: Between 2012 and 2017, 35 patients with metastatic EGFR Exon20ins NSCLC were included and paired with 76 patients with classic EGFR exon 19/21 deletion/mutation metastatic NSCLC (control group).